During the past 25 years, the Joslin Diabetes Center Diabetes Research Center (DRC) has stimulated and nurtured diabetes research at the Joslin and in the surrounding Harvard Medical School community. The DRC, with its Core Laboratories, Enrichment Program, and support for Pilot and Feasibility (P&F) studies, has provided critical infrastructure for basic, translational, and clinical research, and provided an outstanding intellectual enrichment base for diabetes researchers at Joslin and across the Harvard/Longwood medical area. Having a robust and adaptable DRC administrafive structure is critical for maintaining and coordinating the quality, effectiveness, and efficiency of the DRC core services, and for providing the vision that allows the DRC to adapt to changing needs and discoveries in the field of diabetes research especially now to implement the planned expansion of research efforts at Joslin. The purpose of the Joslin Diabetes Center DRC Administrafive Component is to: 1) Manage the DRC in a manner that ensures: a) strength in its leadership, b) quality, efficiency, and oversight in its Cores, and c) promotion of a stimulating, interactive, and collaborative scientific environment that advances diabetes research in the nearby Harvard community and greater Boston area. 2) Adapt to progress in scientific and informafion technology so that: a) the DRC Cores maintain cutting edge relevance with respect to the services they offer and b) information and computing technologies are leveraged to provide maximal efficiency and quality for DRC operations.

Public Health Relevance

The Administrative Component ofthe Joslin Diabetes Center DRC is essenfial to manage the Core Laboratories, Pilot and Feasibility Program and Enrichment Program that facilitate research directed to prevention, better treatments, and a cure for diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK036836-26A1
Application #
8441737
Study Section
Special Emphasis Panel (ZDK1-GRB-S (O2))
Project Start
Project End
Budget Start
2012-09-14
Budget End
2013-08-31
Support Year
26
Fiscal Year
2012
Total Cost
$259,822
Indirect Cost
$102,275
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Qi, Weier; Li, Qian; Gordin, Daniel et al. (2018) Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism. J Mol Med (Berl) 96:373-381
Adachi, Yusuke; De Sousa-Coelho, Ana Luisa; Harata, Ikue et al. (2018) l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism. Mol Metab 17:61-70
Berkowitz, Robert I; Marcus, Marsha D; Anderson, Barbara J et al. (2018) Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 19:191-198
Musen, Gail; Tinsley, Liane J; Marcinkowski, Katrina A et al. (2018) Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications. Diabetes Care 41:1749-1756
Stanford, Kristin I; Lynes, Matthew D; Takahashi, Hirokazu et al. (2018) 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab 27:1357
Shah, Hetal S; Morieri, Mario Luca; Marcovina, Santica M et al. (2018) Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD. Diabetes Care 41:348-355
Mul, Joram D; Soto, Marion; Cahill, Michael E et al. (2018) Voluntary wheel running promotes resilience to chronic social defeat stress in mice: a role for nucleus accumbens ?FosB. Neuropsychopharmacology 43:1934-1942
Morieri, Mario Luca; Gao, He; Pigeyre, Marie et al. (2018) Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial. Diabetes Care 41:2404-2413
Rezanejad, Habib; Ouziel-Yahalom, Limor; Keyzer, Charlotte A et al. (2018) Heterogeneity of SOX9 and HNF1? in Pancreatic Ducts Is Dynamic. Stem Cell Reports 10:725-738
Katz, Michelle L; Guo, Zijing; Cheema, Alina et al. (2018) Management of Cardiovascular Disease Risk in Teens with Type 1 Diabetes: Perspectives of Teens With and Without Dyslipidemia and Parents. Pediatr Diabetes :

Showing the most recent 10 out of 1120 publications